Answers are grounded in this paper and cite their sources.
Protein tyrosine phosphorylation is a critical regulator of podocyte function, controlling cell adhesion, signaling, and cytoskeletal architecture. The receptor-type protein tyrosine phosphatase PTPRO (GLEPP1) is highly expressed in podocytes, and its dysregulation contributes to podocytopathies. However, the mechanisms controlling PTPRO expression under stress remain incompletely understood. Here, we demonstrate that PTPRO is expressed in conditionally immortalized human podocytes and is dynamically regulated. Exposure to the pro-fibrotic cytokine TGF-β induced an upregulation of PTPRO, accompanied by a concomitant downregulation of microRNA-26b (miR-26b), which we identified as a post-transcriptional regulator of PTPRO. Furthermore, the podocyte stressor puromycin aminonucleoside markedly suppressed PTPRO expression, whereas glucocorticoids induced PTPRO, highlighting context-dependent regulation. These results reveal a novel TGF-β/miR-26b/PTPRO signaling axis that modulates podocyte cytoskeletal integrity and underscores the complexity of targeting phosphatase pathways therapeutically in proteinuric kidney diseases, including both steroid-sensitive and steroid-resistant forms.
No takes yet. Share an insight, caveat, or question.
Sopel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: